A federal judge on Tuesday barred the Justice Department from sharing former special counsel Jack Smith's final report on the classified documents case against Donald Trump with members of Congress.

We torture-test a dozen of the most popular text-to-image AI tools with a series of prompts designed to highlight their strengths and weaknesses. Here's how they stack up. I've been writing about ...

An English Court of Appeal decision broadening the scope of the salaried members rules, which recharacterise members of limited liability partnerships (LLPs) as employees for tax purposes, is likely ...

National Institutes of Health (NIH) Acting Director Matthew Memoli sought ... prioritization," but noted that due to "confusion on the scope of the pause" he wanted to provide additional guidance.

Kennedy and Martin Luther King, Jr. In an order signed last week, Trump ordered the Director of National Intelligence and the attorney general to review the related documents "and present a plan ...

We may have gotten an early peek at Apple's upcoming iPhone SE 4, courtesy of photos and a video shared by a leaker via X. The photos and clip, posted by an account dubbed Majin Bu, show off what ...

Just about everyone online was either employed by, or receiving grants from, the National Institutes of Health (NIH), the largest single funder of biomedical and behavioral research in the world.

The financial services profession should be open to anyone with a passion for it and a determination to succeed. Yet, we know that diversity in the profession is still a work in progress.

One week in, the Trump administration is broadening its assault on the functions of government and shifting control of the federal purse strings further away from members of Congress. President ...

The satellite images show the word “help” had been spelled out about a dozen times on the piece of land that is owned by the Union Pacific Railroad. The Spanish words for “trafficking ...

A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to clinical trials, purchasing, research publications and public appearances.